Abstract
Inclusion and exclusion criteria for the diagnosis of acute transverse myelitis (ATM), as a basis for multicenter clinical trials, are proposed by a Transverse Myelitis Consortium Working Group.
Highlights
Inclusion and exclusion criteria for the diagnosis of acute transverse myelitis (ATM), as a basis for multicenter clinical trials, are proposed by a Transverse Myelitis Consortium Working Group
Identification of known etiologies can lead to specific treatments whereas idiopathic ATM, that constitutes about 16% of cases, has no established therapy
More than 200 cases of postvaccinal encephalomyelitis were reported in England in 1922-3, a complication of smallpox and rabies vaccination (Rivers TM, 1929)
Summary
Inclusion and exclusion criteria for the diagnosis of acute transverse myelitis (ATM), as a basis for multicenter clinical trials, are proposed by a Transverse Myelitis Consortium Working Group. Point prevalence of motor tics ranged from 3.2% to 9.6% (overall frequency 24.4%). Point prevalence of behavioral problems ranged from 2.6% to 11.0% (overall frequency 25.7%).
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
